Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast period 2019-2025. The Global Radiopharmaceuticals Industry Report gives an elaborate information about the market size, share and analyzes the complete value chain the report also covers the market dynamics enriching business strategists with quality data about the Radiopharmaceuticals market.
This research report categorizes the global Radiopharmaceuticals market by players/brands, region, type, and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The proportion of Diagnostic Radioisotopes in 2016 is about 89.22%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 62.63%.
In 2017, the global Radiopharmaceuticals market size was 4900 million US$ and is forecast to 8410 million US in 2025, growing at a CAGR of 8.0% from 2018. The objectives of this study are to define, segment, and project the size of the Radiopharmaceuticals market based on company, product type, application and key regions.
The various contributors involved in the value chain of Radiopharmaceuticals include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Radiopharmaceuticals include
China Isotope & Radiation
Advanced Accelerator Applications
Market Size Split by Type
Market Size Split by Application
Market size split by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Radiopharmaceuticals market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Radiopharmaceuticals market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
1 Study Coverage
1.1 Radiopharmaceuticals Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Radiopharmaceuticals Market Size Growth Rate by Type
1.4.2 Diagnostic Radioisotopes
1.4.3 Therapeutic Radioisotopes
1.5 Market by Application
1.5.1 Global Radiopharmaceuticals Market Size Growth Rate by Application
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals Market Size
2.1.1 Global Radiopharmaceuticals Revenue 2016-2025
2.1.2 Global Radiopharmaceuticals Sales 2016-2025
2.2 Radiopharmaceuticals Growth Rate by Regions
2.2.1 Global Radiopharmaceuticals Sales by Regions
2.2.2 Global Radiopharmaceuticals Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Radiopharmaceuticals Sales by Manufacturers
3.1.1 Radiopharmaceuticals Sales by Manufacturers
3.1.2 Radiopharmaceuticals Sales Market Share by Manufacturers
3.1.3 Global Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.2 Radiopharmaceuticals Revenue by Manufacturers
3.2.1 Radiopharmaceuticals Revenue by Manufacturers (2016-2018)
3.2.2 Radiopharmaceuticals Revenue Share by Manufacturers (2016-2018)
3.3 Radiopharmaceuticals Price by Manufacturers
3.4 Radiopharmaceuticals Manufacturing Base Distribution, Product Types
3.4.1 Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Radiopharmaceuticals Product Category
3.4.3 Date of International Manufacturers Enter into Radiopharmaceuticals Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Radiopharmaceuticals Sales by Type
4.2 Global Radiopharmaceuticals Revenue by Type
4.3 Radiopharmaceuticals Price by Type
5 Breakdown Data by Application
5.2 Global Radiopharmaceuticals Breakdown Data by Application
6 North America
6.1 North America Radiopharmaceuticals by Countries
6.1.1 North America Radiopharmaceuticals Sales by Countries
6.1.2 North America Radiopharmaceuticals Revenue by Countries
6.1.3 United States
6.2 North America Radiopharmaceuticals by Type
6.3 North America Radiopharmaceuticals by Application
6.4 North America Radiopharmaceuticals by Company
7.1 Europe Radiopharmaceuticals by Countries
7.1.1 Europe Radiopharmaceuticals Sales by Countries
7.1.2 Europe Radiopharmaceuticals Revenue by Countries
7.2 Europe Radiopharmaceuticals by Type
7.3 Europe Radiopharmaceuticals by Application
7.4 Europe Radiopharmaceuticals by Company
8 Asia Pacific
8.1 Asia Pacific Radiopharmaceuticals by Countries
8.1.1 Asia Pacific Radiopharmaceuticals Sales by Countries
8.1.2 Asia Pacific Radiopharmaceuticals Revenue by Countries
8.2 Asia Pacific Radiopharmaceuticals by Type
8.3 Asia Pacific Radiopharmaceuticals by Application
8.4 Asia Pacific Radiopharmaceuticals by Company
9 Central & South America
9.1 Central & South America Radiopharmaceuticals by Countries
9.1.1 Central & South America Radiopharmaceuticals Sales by Countries
9.1.2 Central & South America Radiopharmaceuticals Revenue by Countries
9.2 Central & South America Radiopharmaceuticals by Type
9.3 Central & South America Radiopharmaceuticals by Application
9.4 Central & South America Radiopharmaceuticals by Company
10 Middle East and Africa
10.1 Middle East and Africa Radiopharmaceuticals by Countries
10.1.1 Middle East and Africa Radiopharmaceuticals Sales by Countries
10.1.2 Middle East and Africa Radiopharmaceuticals Revenue by Countries
10.1.3 GCC Countries
10.1.6 South Africa
10.2 Middle East and Africa Radiopharmaceuticals by Type
10.3 Middle East and Africa Radiopharmaceuticals by Application
10.4 Middle East and Africa Radiopharmaceuticals by Company
11 Company Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.1.4 Radiopharmaceuticals Product Description
11.1.5 Recent Development
11.2.1 Bayer Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.2.4 Radiopharmaceuticals Product Description
11.2.5 Recent Development
11.3.1 Mallinckrodt Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.3.4 Radiopharmaceuticals Product Description
11.3.5 Recent Development
11.4.1 Nordion Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.4.4 Radiopharmaceuticals Product Description
11.4.5 Recent Development
11.5 Triad Isotopes
11.5.1 Triad Isotopes Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.5.4 Radiopharmaceuticals Product Description
11.5.5 Recent Development
11.6.1 Lantheus Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.6.4 Radiopharmaceuticals Product Description
11.6.5 Recent Development
11.7 IBA Group
11.7.1 IBA Group Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.7.4 Radiopharmaceuticals Product Description
11.7.5 Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.8.4 Radiopharmaceuticals Product Description
11.8.5 Recent Development
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.9.4 Radiopharmaceuticals Product Description
11.9.5 Recent Development
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Radiopharmaceuticals
11.10.4 Radiopharmaceuticals Product Description
11.10.5 Recent Development
11.11 Eli Lilly
11.12 Advanced Accelerator Applications
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Radiopharmaceuticals Raw Material
13.1.2 Radiopharmaceuticals Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
14 Research Findings and Conclusion
The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks read more..
Opioids Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast read more..
The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..
The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also read more..
The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and read more..
The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and read more..
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..
The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also read more..